A novel vaccinia oncolysate vaccine shows promise as an active immunotherapy for human cancers. Early trials indicate it safely stimulates the immune system, with some patients experiencing tumor reduction.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: